MiR-125b targets BCL3 and suppresses ovarian cancer proliferation
✍ Scribed by Yi Guan; Hailan Yao; Zhihong Zheng; Guangrong Qiu; Kailai Sun
- Book ID
- 102865259
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- French
- Weight
- 796 KB
- Volume
- 128
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Micro‐RNAs (miRNAs) important for post‐transcriptional gene expression as negative regulators are endogenous 21‐ to 23‐nucleotide noncoding RNAs. Many miRNAs are expressed in ovarian cancer (OC). In this study, we reported that miR‐125b was underexpressed in human OC specimens. Ectopic expression of miR‐125b in OC cells induced cell cycle arrest and led to reduction in proliferation and clonal formation. This inhibitory effect on OC cell growth was mediated by miR‐125b inhibition of the translation of an mRNA encoding a proto‐oncogene, BCL3. Furthermore, expression of miR‐125b suppressed the tumor formation generated by injecting OC cells in nude mice. Our results suggest that aberrantly expressed miR‐125b may contribute to OC development.
📜 SIMILAR VOLUMES
## Abstract microRNAs are endogenous small noncoding RNAs that regulate gene expression negatively at posttranscriptional level. This latest addition to the complex gene regulatory circuitry revolutionizes our way to understanding physiological and pathological processes in the human body. Here we
## Abstract Increasing evidence has suggested that dysregulation of certain microRNAs (miRNAs) may contribute to tumorigenesis. microRNA‐125b (miR‐125b) was implicated to have close relationship with cell proliferation and differentiation, and downregulation of miR‐125b was observed in various type
MicroRNAs (miRNAs) are small, noncoding RNAs that can act as oncogenes or tumor suppressors in human cancer. Our previous study showed that miR-125b was a prognostic indicator for patients with hepatocellular carcinoma (HCC), but its functions and exact mechanisms in hepatic carcinogenesis are still